As a leader in rare diseases, we are committed to improving the lives of people with rare diseases. We work together with a range of partners to bring innovative, transformational therapies to the people who need them.

Our local and regional reach gives our partners access to over 70 countries with a total of more than 1 billion inhabitants.

Our partnering model has been the basis for our successful haemophilia portfolio as well as numerous other product launches over the years within varying indications.  

We are always open for new partnerships, particularly for product opportunities with a high degree of innovation, and which fulfil unmet medical needs.

To find out more, please contact Sobi Corporate Development Team at